# Low Versus High Dose Magnesium Sulfate in the Early Management of Rapid Atrial Fibrillation

> **NCT00965874** · PHASE3 · COMPLETED · sponsor: **University of Monastir** · enrollment: 450 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Magnesium Sulfate high dose
- **DRUG:** Magnesium Sulfate low dose
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT00965874
- **Lead sponsor:** University of Monastir
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2014-04
- **Final completion:** 2014-08
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2018-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965874, "Low Versus High Dose Magnesium Sulfate in the Early Management of Rapid Atrial Fibrillation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00965874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*